Last Updated: November 8, 2026

Details for Patent: 7,531,530

Name: Drug Patent Intelligence for US Patent 7531530
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Summary for Patent: 7,531,530

Title:	Therapeutic compounds
Abstract:	The invention relates to trycyclic lactam indole derivatives and triacyclic lactam benzimodole derivatives and their use in inhibiting the activity of PARP enzyme. The invention also relates to the use of these compounds in the preparation of medicaments.
Inventor(s):	Thomas Helleday, Nicola Curtin
Assignee:	Pfizer Corp Belgium , Cancer Research Technology Ltd , Pfizer Corp SRL
Application Number:	US10/565,308
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 7,531,530

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,531,530

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0317466.1	Jul 25, 2003
United Kingdom	0408524.7	Apr 16, 2004

PCT Information
PCT Filed	July 23, 2004	PCT Application Number:	PCT/GB2004/003183
PCT Publication Date:	February 10, 2005	PCT Publication Number:	WO2005/012305

International Family Members for US Patent 7,531,530

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	454893	⤷ Start Trial
Austria	516353	⤷ Start Trial
Australia	2004261462	⤷ Start Trial
Australia	2004261779	⤷ Start Trial
Brazil	PI0412899	⤷ Start Trial
Brazil	PI0412909	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.